Skanska Awarded $215M Contract to Build Biomanufacturing Facility for Seagen in Washington, USA

Skanska Awarded $215M Contract to Build Biomanufacturing Facility for Seagen in Washington, USA

(IN BRIEF) Skanska has secured a contract with Seagen to build a 25,000 square meter biomanufacturing facility in Everett, Washington, USA. The facility will encompass manufacturing, storage, shipping, office, and café spaces. The contract is valued at USD 215 million (SEK 2.25 billion) and will be included in Skanska’s U.S. order bookings for the third quarter of 2023. Construction is already in progress, and the project is expected to be completed by the fourth quarter of 2024.

(PRESS RELEASE) STOCKHOLM, 5-Aug-2023 — /EuropaWire/ — Skanska has finalized a contract with Seagen to construct a 25,000 square meter biomanufacturing facility for the global biotechnology company. The facility will include manufacturing, storage, shipping, office, and café space in Everett, Washington, USA. The contract is worth USD 215 M, about SEK 2.25 billion, which will be included in the U.S. order bookings for the third quarter, 2023.

Seagen announced their plans to build the project in April 2022. Construction is underway and completion is anticipated for Q4, 2024.

Media Contact:

Daniela Arellano
Director – Communications Building

Olof Rundgren
Communication Specialist
Telephone +46104486794

SOURCE: Skanska